| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.26 | 3e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |